T1	Participants 812 982	Patients aged 18-80 years were eligible for enrolment if they had stable VT, previous myocardial infarction, and reduced left-ventricular ejection fraction (LVEF; <or=50%
T2	Participants 985 1036	110 patients were randomly allocated in a 1:1 ratio
T5	Participants 2456 2535	Nine patients died during the study (ablation group, five; control group, four)
T6	Participants 759 811	undertaken in 16 centres in four European countries.
